Blood lipid profile
Multiple randomised trials and meta-analyses report LDL cholesterol reductions of roughly 15 to 25 percent, comparable to a low-dose statin. That is unsurprising: the active compound is chemically identical to lovastatin. The uncertainty is not whether it works but how much of it any given product contains.
What may be going on: Monacolin K inhibits HMG-CoA reductase, the same enzyme targeted by prescription statins.
Strong evidence. Consistent findings across multiple good-quality human studies.
View the 2 sources
- Safety and Efficacy of the Consumption of the Nutraceutical "Red Yeast Rice Extract" for the Reduction of Hypercholesterolemia in Humans: A Systematic Review and Meta-Analysis.(opens in a new tab)
Meta-analysis · Nutrients · 2024 · PMID 38794691
- Monacolin K supplementation in patients with hypercholesterolemia: A systematic review of clinical trials.(opens in a new tab)
Systematic review · Semergen · 2024 · PMID 38310834
Deep research mode adds each paper’s own conclusion and stated limitations.